Vardenafil Hydrochloride Trihydrate(CAS: 330808-88-3)

Vardenafil Hydrochloride Trihydrate (CAS: 330808-88-3) is a crystalline solid with a molecular weight of approximately 633.8 g/mol. It has a solubility of about 25 mg/mL in water and exhibits limited solubility in organic solvents. Chemically, it is highly stable under normal conditions but can degrade upon exposure to moisture and heat. It is moderately reactive with bases and can undergo hydrolysis under acidic conditions.

Vardenafil Hydrochloride Trihydrate is typically synthesized via a multi-step process involving the synthesis of the parent vardenafil molecule followed by the addition of hydrochloric acid and water to form the trihydrate. The synthesis involves protecting groups, coupling reactions, and deprotection steps. The final product is crystallized from a suitable solvent, and the trihydrate form is obtained by hydrating the hydrochloride salt under controlled conditions.

Vardenafil Hydrochloride Trihydrate (CAS: 330808-88-3) is primarily used in the pharmaceutical industry for the production of the erectile dysfunction drug Levitra. It is also explored for other therapeutic applications, including potential uses in treating benign prostatic hyperplasia and pulmonary arterial hypertension. Additionally, its chemical structure and properties may be of interest in academic research and other specialized fields.

When handling Vardenafil Hydrochloride Trihydrate (CAS: 330808-88-3), it is important to wear appropriate personal protective equipment (PPE) such as gloves and safety goggles. Store the compound in a cool, dry place away from moisture and heat. Use a fume hood during handling to avoid inhalation of dust or aerosols. In case of a spill, promptly clean up using appropriate procedures and ensure proper disposal. Always refer to the Safety Data Sheet (SDS) for specific handling instructions and emergency procedures.